FdaApplication
ANDA 215582
Identifiers
- fda_app_no: ANDA215582
Properties
| Property | Value |
|---|---|
| applicant_name | QUAGEN PHARMACEUTICALS LLC |
| application_type | ANDA |
| approval_date | 2025-10-22 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ARIPIPRAZOLE | ARIPIPRAZOLE | 1MG/ML | SOLUTION;ORAL |
1 product